Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
Price Target
Average
--9.64%
Revenue Forecast
Estimate
14.15%
EBIT
Estimate
12.10%
Net Income
Estimate
24.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Halozyme Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HALO of $54 , with forecasts ranging from
a
low of
$44 to a high of $65 .
HALO Lowest Price Target
Wall Street Target
44 USD
-26.37%
HALO Average Price Target
Wall Street Target
54 USD
-9.64%
HALO Highest Price Target
Wall Street Target
65 USD
8.77%
REVENUE FORECAST
Revenue Forecast Chart HALO
EBIT FORECAST
EBIT Forecast Chart HALO
NET INCOME FORECAST
Net Income Chart HALO